This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (28)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Otolaryngology/ Head & Neck Surgery  • Surgery  • Surgical Interventions  • Endocrine Surgery  • Pediatric Surgery  • Endocrine Diseases  • Thyroid/ Parathyroid Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Paolo Miccoli, MD; Alessandro Antonelli, MD; Claudio Spinelli, MD; Marco Ferdeghini, MD; Poupak Fallahi, MD; Lidio Baschieri, MD

Arch Surg. 1998;133:89-93.

Objective  To evaluate the usefulness of submitting children with thyroid cancer secondary to nuclear accidents to a completion total thyroidectomy.

Design  A case series consisting of patients living and operated on in Belarus whose parents had asked for a clinical evaluation in a western European center.

Setting  A tertiary care referral center.

Patients  The conditions of 47 children from Gomel, Belarus, with differentiated thyroid carcinoma following the nuclear accident at Chernobyl, Ukraine, were evaluated at the University of Pisa, Pisa, Italy. In approximately half of the cases, the treatment in Belarus consisted of a hemithyroidectomy. After a complete evaluation, the decision was made to reoperate on 19 of them by performing a completion total thyroidectomy. The preoperative evaluation revealed that 5 (26%) of the 19 patients who had undergone a hemithyroidectomy had unilateral recurrent nerve palsy and that 2 (10.5%) had hypoparathyroidism.

Interventions  Neck ultrasonography was used for the preoperative localization of thyroid residuals, thyroid nodules, suspicious lymph nodes, and a guided fine-needle aspiration biopsy specimen. The circulating thyroglobulin measurement was obtained before reoperation. An iodine 131 whole-body scan (WBS) was performed and circulating thyroglobulin levels were obtained after completion of the thyroidectomy during withdrawal of levothyroxine sodium therapy.

Main Outcome Measure  The number of patients with a recurrence of thyroid cancer and lung or lymph node metastases after the completion total thyroidectomy.

Results  The results of the histologic examination were positive for papillary thyroid cancer in 6 (28.6%) of 21 patients, 3 with residual cancer in the remaing thyroid lobe and 3 with metastatic lymph node disease. A posttherapy WBS demonstrated lung metastases in 5 (28%) of 18 patients and lymph node metastases in 6 (33%) of 18 patients; the results of a posttherapy WBS were negative for metastases in 7 (39%) of 18 patients. Hypoparathyroidism developed in 4 (21%) of 19 patients who underwent a completion total thyroidectomy; unilateral laringeal nerve palsy developed in 1 (5.2%) of these 19 patients. Among 22 children who previously underwent total thyroidectomy in Belarus, a diagnostic WBS showed lung metastases in 10 (45%) of the children and lymph node metastases alone in 3 (14%) of the children; the results of a diagnostic WBS were negative for metastases in 9 (41%) of the children. Statistical analysis showed a nonsignificant (P>.05) difference in the prevalence of lung and lymph node metastases in patients who previously underwent total thyroidectomy compared with patients who underwent completion total thyroidectomy.

Conclusion  Completion total thyroidectomy allowed for the diagnosis and treatment of recurrent thyroid cancer and lung or lymph node metastases in 61% (11/18) of the patients in whom residual differentiated thyroid carcinoma was not previously recognized.

From the Endocrine Surgery Unit (Drs Miccoli and Spinelli), Clinical Medicine II (Drs Antonelli, Fallahi, and Baschieri), and Nuclear Medicine (Dr Ferdeghini), University of Pisa, Pisa, Italy. (Dr Baschieri is deceased.)

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review
Jarzab et al.
Endocr Relat Cancer 2005;12:773-803.
ABSTRACT | FULL TEXT  

A Randomized Trial of Remnant Ablation--In Search of an Impossible Dream?
Mazzaferri
J. Clin. Endocrinol. Metab. 2004;89:3662-3664.
FULL TEXT  

Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia
Antonelli et al.
QJM 2004;97:499-506.
ABSTRACT | FULL TEXT  

Radioiodine Dose for Remnant Ablation in Differentiated Thyroid Carcinoma: A Randomized Clinical Trial in 509 Patients
Bal et al.
J. Clin. Endocrinol. Metab. 2004;89:1666-1673.
ABSTRACT | FULL TEXT  

Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer
Mazzaferri and Kloos
J. Clin. Endocrinol. Metab. 2001;86:1447-1463.
FULL TEXT